MSLN and ovarian carcinoma: Mesothelin (MSLN) is a differentiation antigen with high expression in ovarian cancer but low in normal tissues,4 and typically associated with chemoresistance and poor prognosis in advanced EOC.5 In our previous study, targeting mesoCAR-T cells significantly suppressed the growth of MSLN-positive ovarian cancer in vitro and in vivo.6